{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T20:55:36Z","timestamp":1715979336204},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,10,30]],"date-time":"2011-10-30T00:00:00Z","timestamp":1319932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s12032-011-0094-7","type":"journal-article","created":{"date-parts":[[2011,10,29]],"date-time":"2011-10-29T07:33:28Z","timestamp":1319873608000},"page":"2311-2316","source":"Crossref","is-referenced-by-count":5,"title":["Angioimmunoblastic T-cell lymphoma: the effect of initial treatment and microvascular density in 31 patients"],"prefix":"10.1007","volume":"29","author":[{"given":"Shu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guodong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,30]]},"reference":[{"key":"94_CR1","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Armitage","year":"2008","unstructured":"Armitage J, Vose J, Weisenburger D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124\u201330.","journal-title":"J Clin Oncol"},{"key":"94_CR2","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","volume":"111","author":"N Mourad","year":"2008","unstructured":"Mourad N, Mounier N, Bri\u00e8re J, et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) trials. Blood. 2008;111:4463\u201370.","journal-title":"Blood"},{"key":"94_CR3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/labinvest.3700697","volume":"88","author":"D Gratzinger","year":"2008","unstructured":"Gratzinger D, Zhao S, Tibshirani RJ, et al. Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. Lab Invest. 2008;88:38\u201347.","journal-title":"Lab Invest"},{"key":"94_CR4","unstructured":"Jaffe ES, Ralfkiaer E (2001) Angioimmunobalstic T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al. (eds) World health organisation classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 225\u2013226."},{"key":"94_CR5","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2353\/ajpath.2007.060901","volume":"70","author":"D Gratzinger","year":"2007","unstructured":"Gratzinger D, Zhao S, Marinelli RJ, et al. Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes. Am J Pathol1. 2007;70:1362\u20139.","journal-title":"Am J Pathol1"},{"key":"94_CR6","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"The Non-Hodgkin\u2019s Lymphoma Classification Project","year":"1997","unstructured":"The Non-Hodgkin\u2019s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma: The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood. 1997;89:3909\u201318.","journal-title":"Blood"},{"key":"94_CR7","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. (2008) WHO Classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC, p 439."},{"key":"94_CR8","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood-2006-01-0394","volume":"108","author":"L Krenacs","year":"2006","unstructured":"Krenacs L, Schaerli P, Kis G, et al. Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells. Blood. 2006;108:1110\u20131.","journal-title":"Blood"},{"key":"94_CR9","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L Leval de","year":"2007","unstructured":"de Leval L, Rickman DS, Thielen C, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T cells (TFH). Blood. 2007;109:4952\u201363.","journal-title":"Blood"},{"key":"94_CR10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nri1714","volume":"5","author":"CG Vinuesa","year":"2005","unstructured":"Vinuesa CG, Tangye SG, Moser B, et al. Follicular B helper T cells in antibody response and autoimmunity. Nat Rev Immunol. 2005;5:853\u201365.","journal-title":"Nat Rev Immunol"},{"key":"94_CR11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","volume":"99","author":"A Attygalle","year":"2002","unstructured":"Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood. 2002;99:627\u201333.","journal-title":"Blood"},{"key":"94_CR12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1365-2141.2003.04335.x","volume":"121","author":"A Dogan","year":"2003","unstructured":"Dogan A, Attygalle AD, Kyriakou C. Angioimunoblastic T-cell lymphoma. Br J Haematol. 2003;121:681\u201391.","journal-title":"Br J Haematol"},{"key":"94_CR13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","volume":"30","author":"J Dupuis","year":"2006","unstructured":"Dupuis J, Boye K, Martin N, et al. Expression of CXCL13 by neoplastic cells in Angioimmunoblastic T cell-lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol. 2006;30:490\u20134.","journal-title":"Am J Surg Pathol"},{"key":"94_CR14","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2005-03-1083","volume":"106","author":"KL Grogg","year":"2005","unstructured":"Grogg KL, Attygalle AD, Macon WR, et al. Angioimmunoblastic T cell lymphoma: a neoplasm of germinal-center T-helper cells? Blood. 2005;106:1501\u20132.","journal-title":"Blood"},{"key":"94_CR15","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood-2004-03-1206","volume":"104","author":"CH Kim","year":"2004","unstructured":"Kim CH, Lim HW, Kim JR, et al. Unique gene expression program of human germinal center T helper cells. Blood. 2004;104:1952\u201360.","journal-title":"Blood"},{"key":"94_CR16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.humpath.2005.05.008","volume":"36","author":"CM Yuan","year":"2005","unstructured":"Yuan CM, Vergilio JA, Zhao XF, et al. CD10 and BCL6 expression in the diagnosis of angioimmunoblastic T-cell lymphoma: utility of detecting CDl0+ T -cells by flow cytometry. Hum Pathol. 2005;36:784\u201391.","journal-title":"Hum Pathol"},{"key":"94_CR17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4049\/jimmunol.173.1.68","volume":"173","author":"T Chtanova","year":"2004","unstructured":"Chtanova T, Tangye SG, Newton R, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1\/Th2 effector cells that provide help for B cells. J Immunol. 2004;173:68\u201378.","journal-title":"J Immunol"},{"key":"94_CR18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/35018581","volume":"406","author":"KM Ansel","year":"2000","unstructured":"Ansel KM, Ngo VN, Hyman PL, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 2000;406:309\u201314.","journal-title":"Nature"},{"key":"94_CR19","first-page":"224","volume":"38","author":"XF Tang","year":"2009","unstructured":"Tang XF, Li GD, Li YL, et al. Expressions of CXCL13, CD10 and bcl-6 in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified. Zhonghua Bing Li Xue Za Zhi. 2009;38:224\u201330.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"94_CR20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.3800625","volume":"19","author":"KL Grogg","year":"2006","unstructured":"Grogg KL, Attygalle AD, Macon WR, et al. Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol. 2006;19:1101\u20137.","journal-title":"Mod Pathol"},{"key":"94_CR21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/10428199909058412","volume":"32","author":"P Pautier","year":"1999","unstructured":"Pautier P, Devidas A, Delmer A, et al. Angioimmunoblastic-like T-cell non Hodgkin lymphoma:outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma. 1999;32:545\u201352.","journal-title":"Leuk Lymphoma"},{"key":"94_CR22","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/annonc\/mdh274","volume":"15","author":"AJ Ferreri","year":"2004","unstructured":"Ferreri AJ, Campo E, Ambrosetti A, et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol. 2004;15:1215\u201321.","journal-title":"Ann Oncol"},{"key":"94_CR23","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D. International T-cell Lymphoma Project. International Peripheral T-cell and Natural Killer\/T-Cell Lymphoma Study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124\u201330.","journal-title":"J Clin Oncol"},{"key":"94_CR24","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3109\/10428194.2010.525270","volume":"51","author":"HN Lin","year":"2010","unstructured":"Lin HN, Liu CY, Hong YC, et al. Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience. Leuk Lymphoma. 2010;51:2208\u201314.","journal-title":"Leuk Lymphoma"},{"key":"94_CR25","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2007-02-074641","volume":"110","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Zaja F, Patti C, et al. Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood. 2007;110:2316\u201323.","journal-title":"Blood"},{"key":"94_CR26","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1182\/blood.V106.11.2686.2686","volume":"106","author":"B Joly","year":"2005","unstructured":"Joly B, Frenkel V, Gaulard P. Rituxinmab in combination with CHOP regimen in angioimmunoblastic T-cell lymphoma(AITL). Preliminary results in 9 patients treated in a single institution. Blood. 2005;106:2686.","journal-title":"Blood"},{"key":"94_CR27","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/sj.leu.2403936","volume":"19","author":"I Bruns","year":"2005","unstructured":"Bruns I, Fox F, Reinecke P, et al. Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab. Leukemia. 2005;19:1993\u20135.","journal-title":"Leukemia"},{"key":"94_CR28","first-page":"332","volume":"51","author":"M Mori","year":"2010","unstructured":"Mori M, Inoue D, Arima H, et al. Therapeutic efficacy of cyclosporin A for refractory angioimmunoblastic T cell lymphoma. Rinsho Ketsueki. 2010;51:332\u20138.","journal-title":"Rinsho Ketsueki"},{"key":"94_CR29","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1182\/blood-2010-10-312603","volume":"117","author":"RL Piekarz","year":"2011","unstructured":"Piekarz RL, Frye R, Prince HM, et al. Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood. 2011;117:5827\u201334.","journal-title":"Blood"},{"key":"94_CR30","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1080\/10428190903156729","volume":"50","author":"JM J\u00f8rgensen","year":"2009","unstructured":"J\u00f8rgensen JM, S\u00f8rensen FB, Bendix K, et al. Expression pattern and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR and Flt-4 in Peripheral T-cell lymhoma. Leuk Lymphoma. 2009;50:1647\u201360.","journal-title":"Leuk Lymphoma"},{"key":"94_CR31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/annonc\/mdn666","volume":"20","author":"J Ruan","year":"2009","unstructured":"Ruan J, Hajjar K, Rafii S, Leonard JP. Angiogenesis and antiangiogenic therapy in non-Hodgkin\u2019s lymphoma. Annal Oncol. 2009;20:413\u201324.","journal-title":"Annal Oncol"},{"key":"94_CR32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bmt.1704555","volume":"34","author":"S Kumar","year":"2004","unstructured":"Kumar S, Gertz MA, Dispenzieri A, et al. Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy. Bone Marrow Transplant. 2004;34:235\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"94_CR33","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","volume":"115","author":"J Iqbal","year":"2010","unstructured":"Iqbal J, Weisenburger DD, Greiner TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 2010;115:1026\u201336.","journal-title":"Blood"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-0094-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-011-0094-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-0094-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T18:28:16Z","timestamp":1593196096000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-011-0094-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,30]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["94"],"URL":"https:\/\/doi.org\/10.1007\/s12032-011-0094-7","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,30]]}}}